Abstract
Chemotherapy is arguably the most effective treatment for treating cancer. However, it triggers toxic effects on patients due to its interaction with normal cells. In this paper, we propose a finite-horizon Markov decision process framework for optimal chemotherapy dose selection during cancer treatment. In contrast to many other research works, our model accommodates all possible patient’s clinical health states that could be considered during treatment. We study the use of our model by applying it on Wilms tumor. We explore three different cases of varying transition probabilities and rewards. Our numerical results agree with clinical intuition and demonstrate the potential applicability of our model.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.